Suchergebnisse - (Person:"Barreiro, Pablo")

PubPharm (6)

1

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

enthalten in: AIDS (London, England) | 2013

von Neukam, K. | Caruz, A. | Rivero-Juárez, A. | +10

2

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

enthalten in: AIDS (London, England) | 2011

von Labarga, P. | Barreiro, P. | Mira, J. | +11

3

Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

enthalten in: AIDS (London, England) | 2008

von Rodríguez-Nóvoa, S. | Morello, J. | González, M. | +6

4

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

enthalten in: AIDS (London, England) | 2007

von de Mendoza, C. | Martin-Carbonero, L. | Barreiro, P. | +6

5

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

enthalten in: AIDS (London, England) | 2006

von Soriano, V. | Labarga, P. | Ruiz-Sancho, A. | +2

CommentOn: AIDS. 2006 Nov 14;20(17):2175-81. - PMID 17086057

6

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

enthalten in: AIDS (London, England) | 2003

von Pérez-Olmeda, M. | Núñez, M. | Romero, M. | +9

CommentIn: AIDS. 2004 Jan 2;18(1):131. - PMID 15090841

1
[1]